Clinical Trial Update: Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial assessing sofobuvir plus velpatasvir with or without ribavirin in treatment-experienced chronic Hepatitis C patients; results completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)
• Velpatasvir (velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2016-09-16